Medical device package

ABSTRACT

A medical device package includes a medical device including a first end surface and a second end surface; and a medical device storage container configured to store the medical device, the medical device storage container including a container main body and a holding unit located in the storage space, and configured to hold the medical device such that the first end surface faces upward; and a sheet-like sealing member adapted to be glued to the container main body to seal an opening of the container main body. A surface of the sealing member that faces the container main body includes an adhesive applied area on which an adhesive is applied and an adhesive non-applied area on which the adhesive is not applied, the adhesive non-applied area being an area facing at least the first end surface of the medical device held by the holding unit.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. patentapplication Ser. No. 14/464,195, filed on Aug. 20, 2014, which is acontinuation application filed under 35 U.S.C. §111(a) claiming thebenefit under 35 U.S.C. §§120 and 365(c) of PCT InternationalApplication No. PCT/JP2013/053539, filed on Feb. 14, 2013, which isbased upon and claims the benefit of priority of Japanese ApplicationNo. 2012-033556, filed on Feb. 20, 2012, the entire contents of whichare hereby incorporated by reference in their entireties.

BACKGROUND

Technical Field

The present disclosure relates to a medical device package that storesmedical devices, such as syringes and connectors.

Background Art

Conventionally, for conveyance or storage of syringes before beingfilled with a drug solution or the like, syringe storage containerscapable of holding and storing a plurality of syringes in an uprightstate are widely used. Such syringe storage containers are provided witha box-shaped container main body having an upper surface opening, aholder that holds the plurality of syringes in an upright state, and asealing member that seals the opening of the container main body.

A shelf-like portion that supports the holder is provided inside thecontainer main body. The holder is formed into a plate shape having aplurality of through-holes. The syringe is inserted into thethrough-hole of the holder, and a flange portion provided at an endportion of the syringe is hooked on a peripheral edge of thethrough-hole, so that the syringe is held in the holder. When such asyringe storage container is used, a plurality of syringes can be heldin an upright state such that filling openings for the drug solutionface upward.

Typically, manufacturing of the syringes is performed in a placedifferent from a place where the drug solution is filled. At the placewhere the syringes are manufactured, manufactured syringes are stored inthe syringe storage container, the opening of the syringe storagecontainer is sealed with the sealing member, and the medical devicepackage is assembled. Following that, sterilization processing isapplied to the syringe storage container by causing a high-temperaturevapor or gas to permeate the sealing member, such as high-pressure vaporsterilization (autoclave) or ethylene oxide gas (EOG) sterilization.

The syringe storage container to which the sterilization processing hasbeen applied is conveyed to the place where the drug solution is filled.At the place where the drug solution is filled, the sealing of thesyringe storage container with the sealing member is released, and theholder in which the plurality of syringes is held is taken out from thecontainer main body, and is set to a filling device for filling the drugsolution. Following that, the drug solution is filled in the syringes.

A container that stores medical devices is described in JP 2009-183768Av, for example. The medical container described in JP 2009-183768 Aincludes a tray that supports a syringe body, a vessel into which thetray is fit in, a protection sheet that covers the tray and the syringebody, and a cover sheet that seals the vessel. The cover sheet is a gaspermeable material such as nonwoven polyolefin, and is glued to a flangeof the vessel in a peelable manner. An adhesive to be applied on thecover sheet is applied on one surface at a side facing the flange of thevessel. The protection sheet is arranged inside the vessel, and is usedto prevent bacteria, dust, and the like from entering the syringes afterthe cover sheet is peeled from the vessel.

However, in the medical container described in Patent Literature 1, whenthe sterilization processing is applied to the vessel using ahigh-temperature vapor or gas, the cover sheet is pressed by the vaporor the gas and is deformed to be dented into the vessel. Therefore, thesurface of the cover sheet, on which the adhesive is applied, comes incontact with the protection sheet, and the protection sheet is glued bythe cover sheet.

If the protection sheet is glued by the cover sheet, the protectionsheet is removed together with the cover sheet when the cover sheet ispeeled from the vessel. Therefore, when the cover sheet is peeled fromthe vessel, the syringe is exposed, and bacteria, dust, and the like mayenter the syringe.

When the cover sheet is peeled from the vessel in an environment wherethere are no bacteria, dust, and the like, the protection sheet may notbe used. However, in this case, when the sterilization processing isapplied to the vessel using a high-temperature vapor or gas, the surfaceof the cover sheet, on which the adhesive is applied, comes in contactwith the syringe. As a result, the syringe may be glued by the coversheet, or the adhesive may be transferred to the syringe and attached asa foreign substance. This is not favorable.

SUMMARY OF THE INVENTION

Embodiments of the present invention has been made in view of theforegoing, and one objective is to provide a medical device package inwhich an adhesive on a cover sheet (sealing member) is not attached to aprotection sheet or a medical device in a vessel even if sterilizationprocessing is applied to the vessel (container main body) using a vaporor a gas.

To solve certain problems with the prior art devices and to achievecertain objectives of embodiments of the present invention, the medicaldevice package of one embodiment of present invention includes a medicaldevice including a first end surface and a second end surface, and amedical device storage container that stores the medical device. Themedical device storage container includes a container main body and asheet-like sealing member.

The container main body includes a peripheral wall portion including anupper end portion and a lower end portion, a bottom continuing to thelower end portion and surrounded by the lower end portion, an openingsurrounded by the upper end portion, a storage space formed of theperipheral wall portion, the bottom, and the opening, and a holding unitprovided in the storage space and which holds the medical device suchthat the one end surface faces upward.

The sealing member is glued to the container main body, and seals theopening of the container main body. A surface of the sealing member,which faces the container main body, includes an adhesive applied areaon which an adhesive is applied and an adhesive non-applied area onwhich the adhesive is not applied. Then, the adhesive non-applied areais an area facing at least the first end surface of the medical deviceheld in the holding unit.

In the medical device package of the present invention, the adhesivenon-applied area of the sealing member is set to an area facing at leastthe first end surface of the medical device held in the holding unit.Therefore, even if the sealing member comes in contact with the firstend surface of the medical device held in the holding unit when thesealing member is pressed by a vapor or a gas, and is deformed to bedented into the container main body at the time of the sterilizationprocessing, the adhesive is not attached to the medical device. As aresult, the medical device is not glued by the sealing member, and themedical device can be kept in a favorable state.

Further, when an inner sheet (protection sheet) is arranged between themedical device and the sealing member, the adhesive is not attached tothe inner sheet even if the sealing member comes in contact with theinner sheet.

In one embodiment, a medical device package includes a medical deviceincluding a first end surface and a second end surface; and a medicaldevice storage container adapted to store the medical device. Themedical device storage container includes a container main bodyincluding a peripheral wall portion including an upper end portion and alower end portion, a bottom continuing to the lower end portion, andsurrounded by the lower end portion, an opening surrounded by the upperend portion, a storage space formed of the peripheral wall portion, thebottom, and the opening, and a holding unit provided in the storagespace, and adapted to hold the medical device such that the first endsurface faces upward, and a sheet-like sealing member adapted to beglued to the container main body to seal the opening of the containermain body, and a surface of the sealing member, the surface facing thecontainer main body, includes an adhesive applied area on which anadhesive is applied and an adhesive non-applied area on which theadhesive is not applied, and the adhesive non-applied area is an areafacing at least the first end surface of the medical device held in theholding unit.

In one aspect, the medical device is a syringe including the first endsurface and the second end surface, and provided with a filling openingfor allowing a drug solution to be filled in the one end surface. Theholding unit is made of a syringe holding member engaged with an innersurface of the peripheral wall portion to face the bottom, and adaptedto hold the syringe such that the first end surface of the syringe facesupward.

In one aspect, the medical device package includes an inner sheetadapted to cover a side of the first end surface of the syringe held inthe syringe holding member.

In one aspect, the adhesive non-applied area is an area facing at leastthe inner sheet.

In one aspect, the adhesive non-applied area is an area facing at leastthe opening.

In one aspect, the syringe includes a discharge portion forming thesecond end surface and adapted to discharge the drug solution.

In one aspect, the container main body includes a flange portioncontinuing to the upper end portion, and surrounding the upper endportion, and the sealing member is glued to the flange portion.

In one aspect, the sealing member is glued to the container main body bya heat meltable adhesive.

In one aspect, the medical device stored in the container main body issterilizable using a high-pressure vapor that permeates the sealingmember.

According to the medical device package of embodiments of the presentinvention, even if sterilization processing is applied to the containermain body using a vapor or a gas, an adhesive can be made not to attacha medical device in a container main body.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of a medical device package according to afirst embodiment of the present invention.

FIG. 2 is an exploded perspective view of the medical device packageaccording to the first embodiment of the present invention.

FIG. 3 is a perspective view of a container main body in the medicaldevice package according to the first embodiment of the presentinvention.

FIG. 4 is a perspective view of a sealing member in the medical devicepackage according to the first embodiment of the present invention.

FIG. 5 is a partial longitudinal sectional view of the medical devicepackage according to the first embodiment of the present invention.

FIG. 6 is a perspective view of a sealing member in a medical devicepackage according to a second embodiment of the present invention.

FIG. 7 is a perspective view of a sealing member in a medical devicepackage according to a third embodiment of the present invention.

FIG. 8 is a longitudinal sectional view of a medical device packageaccording to a fourth embodiment of the present invention.

FIG. 9 is an exploded view of the medical device package according tothe fourth embodiment of the present invention.

DETAILED DESCRIPTION

Hereinafter, embodiments of a medical device package according toembodiments of the present invention will be described with reference toFIGS. 1 to 9. Note that a common member in the drawings is denoted withthe same reference sign. Further, the present invention is not limitedto the embodiments below.

The description will be given in the following order.

1. First Embodiment of Medical Device Package

2. Second Embodiment of Medical Device Package

3. Third Embodiment of Medical Device Package

4. Fourth Embodiment of Medical Device Package

5. Modification

1. First Embodiment of Medical Device Package

[Configuration of Medical Device Package]

First, a configuration of a medical device package according to thefirst embodiment will be described with reference to FIGS. 1 and 2.

FIG. 1 is a perspective view of a medical device package according tothe first embodiment of the present invention. FIG. 2 is an explodedperspective view of the medical device package according to the firstembodiment of the present invention.

As illustrated in FIGS. 1 and 2, a syringe package 80 representing amedical device package according to the first embodiment is configuredfrom a syringe storage container 1 representing a specific example of amedical device storage container, and a syringe 10 (see FIG. 2)representing a specific example of a medical device stored in thesyringe storage container 1.

The syringe storage container 1 is used to convey or store a pluralityof syringes 10 at the same time. The syringe storage container 1includes a syringe holding member 30 that holds the plurality ofsyringes 10, a container main body 40 that stores the syringe holdingmember 30 holding the plurality of syringes 10, a sealing member 50, andan inner sheet 60.

[Syringe Holding Member]

The syringe holding member 30 represents a specific example of a holdingunit according to the present invention, and holds the syringes 10 in astate where filling openings 15 described below face upward. The syringeholding member 30 is placed on a mounting shelf 44 having a surface 44 a(see FIG. 3) described below of the container main body 40, and faces abottom 41 described below of the container main body 40.

The syringe holding member 30 includes a square flat base plate 31, anda cylinder portion 32 that protrudes from one surface of the base plate31. The base plate 31 is provided with a plurality of through-holes 31 a(see FIG. 5) for allowing the syringes 10 to be inserted.

The through-hole 31 a is formed into a circular shape, and its diameteris larger than an outer diameter of a syringe main body 11 describedbelow of the syringe 10. The plurality of through-holes 31 a is arrangedin the base plate 31 in a zigzag manner. Therefore, distances betweenadjacent through-holes 31 a become equal, and thus contact of theadjacent syringes 10 during conveyance of the syringe storage container1 can be suppressed.

As illustrated in FIG. 2, notches 31 b are formed in two facing sides ofthe base plate 31, respectively. The user can easily take out thesyringe holding member 30 locked in the container main body 40 byinserting his/her fingers into the notches 31 b.

The cylinder portion 32 is formed to cover the through-hole 31 a of thebase plate 31, and includes a cylindrical hole 32 a (see FIG. 5) forallowing the syringe 10 to be inserted. The cylindrical hole 32 acommunicates into the through-hole 31 a. The diameter of the cylindricalhole 32 a is approximately equal to the diameter of the through-hole 31a. A flange portion 16 described below of the syringe 10 is engaged withthe cylinder portion 32.

[Inner Sheet]

The inner sheet 60 is formed into a square sheet shape. The area of theinner sheet 60 is set to have a size that covers a side of the fillingopenings 15 described below of the syringes 10 held in the syringeholding member 30. The inner sheet 60 is placed on the flange portions16 described below of the syringes 10 held in the syringe holding member30.

It is favorable that the inner sheet 60 is permeable by a gas forsterilization and is not permeable by minute particles such as bacteriaor viruses. An example of a material for the inner sheet 60 includesTyvek (registered trademark) that is a high-density polyethylenenonwoven fabric manufactured by Du Pont Kabushiki Kaisha. Note that thesealing member 50 formed of the high-density polyethylene nonwovenfabric is opaque.

[Container Main Body]

Next, the container main body 40 will be described with reference toFIG. 3.

FIG. 3 is a perspective view of the container main body 40.

As illustrated in FIG. 3, the container main body 40 includes aperipheral wall portion 42 including an upper end portion and a lowerend portion, the bottom 41 continuing to the lower end portion of theperipheral wall portion 42 and surrounded by the lower end portion, anopening 40 a surrounded by the upper end portion of the peripheral wallportion 42, and a flange 43 continuing to the upper end portion of theperipheral wall portion 42 and surrounding the upper end portion. Aninternal space of the container main body 40 surrounded by theperipheral wall portion 42, the bottom 41, and the opening 40 a is astorage space that stores the syringe holding member 30 and the syringes10.

The bottom 41 is formed into an approximately square plate shape, andconfigures a lower end of the container main body 40. The size of aninner surface 41 a of the bottom 41 is formed smaller than the baseplate 31 of the syringe holding member 30.

The flange 43 is approximately perpendicular to an upper end of theperipheral wall portion 42, and is formed into a square frame shape. Theflange 43 includes an upper surface 43 a facing an upper end and a lowersurface 43 b facing a lower end. The upper surface 43 a and the lowersurface 43 b are formed into planes. An elongated protrusion 45 isformed on the upper surface 43 a of the flange 43.

The elongated protrusion 45 is provided to surround the opening 40 a,and is endlessly formed along the flange 43. That is, the elongatedprotrusion 45 is formed over the entire periphery of the flange 43. Thesealing member 50 (see FIG. 2) is fused (glued) to the elongatedprotrusion 45. The width of the elongated protrusion 45 is set to besmaller than the width of the flange 43. The width of the elongatedprotrusion 45 is favorably 2 to 10 mm when considering to reliably fusethe sealing member 50 to seal the syringe storage container. Further,the height of the elongated protrusion 45 is favorably 0.2 to 0.5 mm ormore.

An outline of an outer periphery of the elongated protrusion 45 issmaller than an outline of an outer periphery of the flange 43.Therefore, when the sealing member 50 is placed on the elongatedprotrusion 45, the sealing member 50 is less likely to bend toward theopening 40 a of the container main body 40, and the sealing member 50 isreliably placed on the elongated protrusion 45. Therefore, the sealingmember 50 can be reliably fused to the elongated protrusion 45. Further,when the sealing member 50 is peeled, an upper surface positioned at anoutside of the elongated protrusion 45 on the flange 43 can be pressed,and thus the sealing member 50 can be easily peeled.

An outline of an inner periphery of the elongated protrusion 45 islarger than an outline of an outer periphery at the upper end of theperipheral wall portion 42. Therefore, when the sealing member 50 isheat-fused, a receiving jig (not illustrated) can support right underthe elongated protrusion 45, and thus the sealing member 50 can bereliably fused to the elongated protrusion 45.

Further, the elongated protrusion 45 includes square shapes 45 a. Thesesquare shapes 45 a are arranged at four corners of the flange 43, andare formed to have right angles, respectively. Stress is concentrated oneach of the square shapes 45 a when the sealing member 50 is peeled fromthe container main body 40. As a result, the sealing member 50 can beeasily peeled from the square shapes 45 a. Further, since the squareshapes 45 a are positioned at the four corners of the flange 43, andthus when the sealing member 50 is peeled, the sealing member 50 can bealways peeled from the specific places. Further, the sealing member 50is not unintentionally peeled from places other than the four corners ofthe flange 43.

The container main body 40 and the syringe holding member 30 arefavorably not denatured by sterilization processing using ahigh-temperature vapor or gas, such as high-pressure vapor sterilization(autoclave) or an ethylene oxide gas (EOG) sterilization. Examples ofmaterials for the container main body 40 and the syringe holding member30 include resins having excellent durability, such as polypropylene,polystyrene, polyethylene, polycarbonate, an ABS resin, and PET.Further, to secure visibility inside the container main body 40, thecontainer main body 40 and the syringe holding member 30 are favorablysubstantially transparency or translucent, and examples of suchmaterials include polycarbonate, polystyrene, and PET, of theabove-described resins.

[Sealing Member]

Next, the sealing member 50 will be described with reference to FIG. 4.

FIG. 4 is a perspective view of the sealing member 50 in a state where asurface of the sealing member 50, which faces the container main body40, faces upward.

The sealing member 50 is formed into a square sheet shape approximatelyequal to the outline of the outer periphery of the flange 43 (see FIG.3) of the container main body 40. That is, the outline of the outerperiphery of the elongated protrusion 45 provided on the flange 43 isformed smaller than the outline of the outer periphery of the sealingmember 50. The sealing member 50 is heat fused to the flange 43 of thecontainer main body 40 using an adhesive. To be specific, the sealingmember 50 is heat-fused to the elongated protrusion 45 on the flange 43.

It is favorable that the sealing member 50 is permeable by a gas forsterilization and is not permeable by minute particles such as bacteriaor viruses. An example of a material for the sealing member 50 includesTyvek (registered trademark) that is a high-density polyethylenenonwoven fabric manufactured by Du Pont Kabushiki Kaisha. Note that thesealing member 50 formed of the high-density polyethylene nonwovenfabric is opaque.

An adhesive applied area 50 a and an adhesive non-applied area 50 b areformed on a surface of the sealing member 50, the surface facing thecontainer main body 40. A thermoplastic adhesive (hot melt) is appliedon the adhesive applied area 50 a. The adhesive applied area 50 a abutson the elongated protrusion 45 provided on the flange 43 of thecontainer main body 40. Then, an abutting portion of the sealing member50 and the elongated protrusion 45 is warmed by a mold, so that theadhesive is melted, and the sealing member 50 and the elongatedprotrusion 45 are heat-fused (glued).

The adhesive is not applied on the adhesive non-applied area 50 b. Theadhesive non-applied area 50 b is set to an area facing the fillingopening 15 side of the syringes 10 held in the syringe holding member 30(see FIG. 2).

[Syringe]

Next, the syringe 10 will be described with reference to FIG. 5.

FIG. 5 is a partial longitudinal sectional view of the syringe package80.

As illustrated in FIG. 5, the syringe 10 includes a syringe main body 11made of a hollow cylindrical body, a discharge portion 12 formed at atip end side of the syringe main body 11, and a needle tube 13 fixed tothe discharge portion 12. That is, the syringe storage container 1 ofthe present embodiment stores the syringe 10 with a needle.

An outer diameter of the syringe body is smaller than the through-hole31 a and the cylindrical hole 32 a of the syringe holding member 30. Aliquid chamber that accumulates a filled drug solution is formed insidethe syringe main body 11. Further, the filling opening 15 for fillingthe drug solution into the liquid chamber of the syringe main body 11 isformed at a base end side of the syringe main body 11, the base endbeing opposite to the discharge portion 12.

In the present embodiment, an end surface at the filling opening 15 sideof the syringe main body 11 is one end surface, and an end surface ofthe discharge portion 12 is the other end surface.

The flange portion 16 is provided around the filling opening 15 of thesyringe main body 11, an outline of an outer periphery of the flangeportion 16 being formed into an ellipse shape. At least a part (forexample, a long diameter) of the outer diameter of the flange portion 16is formed larger than the diameter of the cylindrical hole 32 a of thesyringe holding member 30. Therefore, the flange portion 16 of thesyringe 10 that is inserted into the cylindrical hole 32 a and thethrough-hole 31 a is placed on an upper end portion of the cylinderportion 32.

Note that the shape of the flange portion 16 is not limited to theellipse shape of the present embodiment, and may be an annulus ringshape, for example.

A cap member 20 is attached to the discharge portion 12. The member 20is formed into an approximately cylindrical shape, and one end in anaxial direction is opened, and the other end in the axial direction isclosed. The cap member 20 covers the discharge portion 12 and the needletube 13 protruding from the discharge portion 12. Examples of a materialfor the cap member 20 include elastic members, such as rubber andelastomer, for example.

The syringe 10 is inserted into the through-hole 31 a provided in thesyringe holding member 30 in a state where the cap member 20 is attachedto the discharge portion 12, and is held in the syringe holding member30.

[Method of Assembling Medical Device Package]

Next, a method of assembling the syringe package 80 will be described.

To assembly the syringe package 80, first, the syringe holding member 30and the container main body 40 are prepared. Then, the base plate 31 ofthe syringe holding member 30 is placed on the mounting shelf 44 of thecontainer main body 40. Accordingly, the syringe holding member 30 isengaged with the container main body 40.

Next, the syringe 10 is inserted into the cylindrical hole 32 a and thethrough-hole 31 a of the syringe holding member 30. The cap member 20 isattached to the discharge portion 12 of the syringe 10, in advance.Accordingly, the syringe 10 to which the cap member 20 is attached isheld in the syringe holding member 30, and is stored in the containermain body 40 (in the state illustrated in FIG. 3).

Next, the inner sheet 60 is placed on the flange portions 16 of aplurality of syringes 10 held in the syringe holding member 30.Accordingly, the filling opening 15 (flange portion 16) side of theplurality of syringes 10 held in the syringe holding member 30 iscovered with the inner sheet 60.

Next, the sealing member 50 is placed on the elongated protrusion 45provided on the flange 43 of the container main body 40. Then, thereceiving jig (not illustrated) abuts on the lower surface 43 b of theflange 43, and a warmed metal mold (not illustrated) presses the sealingmember 50. Accordingly, the adhesive applied on the sealing member 50 ismelted, and the sealing member 50 and the elongated protrusion 45 areheat-fused (glued), and the syringe package 80 is assembled.

Since the lower surface 43 b of the flange 43 is formed into a smoothplane, the thickness of a portion of the flange 43, where the elongatedprotrusion 45 is provided, is secured. Accordingly, the elongatedprotrusion 45 is not deformed by applied heat, and the sealing member 50and the elongated protrusion 45 are reliably heat-fused (sealed) at thetime of heat fusion of the sealing member 50 and the elongatedprotrusion 45.

The metal mold (not illustrated) is formed into a square flat plateshape, for example, and presses the entire surface of the sealing member50. At this time, only the elongated protrusion 45 comes in contact withthe sealing member 50, and thus the sealing member 50 is not heat-fused(is not glued) to an area other than the elongated protrusion 45 of theflange 43. That is, the sealing member 50 can be always heat-fused tothe elongated protrusion 45.

Further, the area of the adhesive applied area 50 a (see FIG. 4) formedon the sealing member 50 is larger than that of the flange 43 of thecontainer main body 40. Therefore, even if the sealing member 50 isshifted from the container main body 40 to some extent, the adhesiveapplied area 50 a of the sealing member 50 can abut on the elongatedprotrusion 45 on the flange 43 of the container main body 40. As aresult, even if the sealing member 50 is shifted from the container mainbody 40 to some extent, the sealing member 50 and the elongatedprotrusion 45 can be glued.

Further, the outline of the outer periphery of the elongated protrusion45 provided on the flange 43 of the container main body 40 is smallerthan the outlines of the outer peripheries of the flange 43 and thesealing member 50, and thus the flange 43 and an outer edge portion ofthe sealing member 50 are not heat-fused (sealed). Therefore, thesealing member 50 can be easily held and the peeling work of the sealingmember 50 can be simply performed when the sealing member 50 is peeledfrom the container main body 40.

After the syringe package 80 is assembled, the syringe package 80 ispackaged with a sterilization packaging bag having an opening, and theopening of the packaging bag is sealed. Next, sterilization processingusing a high-temperature vapor or gas, such as high-pressure vaporsterilization (autoclave) or ethylene oxide gas (EOG) sterilization, isperformed with respect to the syringe package 80 in the packed syringepackaging.

A part of the sterilization packaging bag is formed of, similarly to thesealing member 50, a material that is permeable by the gas forsterilization and is not permeable by minute particles such as bacteriaor viruses. Therefore, the high-temperature vapor or gas, which is thegas for sterilization, can permeate the packaging bag and the syringepackage 80. As a result, the sterilization processing can be performedwith respect to an outer surface of the syringe package 80, the syringeholding member 30 in the syringe package 80, and the syringes 10 held inthe syringe holding member 30.

When the sterilization processing is applied to the syringe package 80,the sealing member 50 is pressed by the high-temperature vapor or gas,and the sealing member 50 is deformed to be dented toward an inside ofthe container main body 40. Accordingly, the surface of the sealingmember 50, the surface facing the container main body 40, abuts on thefilling opening 15 side of the plurality of syringes 10 held by thesyringe holding member 30 across the inner sheet 60 (see FIG. 5).

As described above, the area facing the filling opening 15 side of theplurality of syringes 10, on the surface of the sealing member 50, thesurface facing the container main body 40, is the adhesive non-appliedarea 50 b on which an adhesive is not applied. That is, when thehigh-pressure vapor sterilization is performed, the adhesive non-appliedarea 50 b of the sealing member 50 is deformed toward the fillingopening 15 side of the syringes, and comes in contact with the fillingopenings 15 through the inner sheet 60. Therefore, an area of thesealing member 50 coming in contact with the inner sheet 60 is notapplied the adhesive, and thus the adhesive is not attached to the innersheet 60. As a result, at the time of opening the syringe package 80,the inner sheet 60 is not removed together with the sealing member 50,and a state in which the filling opening 15 side of the plurality ofsyringes 10 is covered with the inner sheet 60 can be maintained.

Note that an area at an inner side of the flange 43, of an area(adhesive applied area 50 a) at an outer side of a portion facing thefilling openings 15 of the plurality of syringes 10, on the surface ofthe sealing member 50, the surface facing the container main body 40, isclose to the elongated protrusion 45 that is a glued portion of thecontainer main body 40 with the sealing member 50. Therefore, in thevicinity of the elongated protrusion 45 (glued portion), the sealingmember 50 is less likely to be deformed into a direction of being closerto the filling openings 15 of the syringes 10. Therefore, the adhesiveapplied area 50 a of the sealing member 50 is less likely to be incontact with the inner sheet 60. Further, there are no syringes 10 belowthe sealing member 50 in the vicinity of the elongated protrusion 45(glued portion). Therefore, even if the sealing member 50 in thevicinity of the elongated protrusion 45 (glued portion) is deformed andcomes in contact with the inner sheet 60, the inner sheet 60 is deformedalong with the sealing member 50, and the adhesive is not attachedenough to the inner sheet 60 to be glued with the sealing member 50.

2. Second Embodiment of Medical Device Package

[Configuration of Medical Device Package]

Next, a configuration of a medical device package according to a secondembodiment will be described with reference to FIG. 6.

FIG. 6 is a perspective view of a sealing member in a medical devicepackage according to the second embodiment.

The medical device package according to the second embodiment isprovided with a configuration similar to the syringe package 80 (seeFIG. 2) of the first embodiment. A difference of the syringe package ofthe second embodiment form the syringe package 80 is only a sealingmember. Therefore, a sealing member 51 in the medical device package ofthe second embodiment will be described.

[Sealing Member]

The sealing member 51 illustrated in FIG. 6 is formed into a squaresheet shape approximately equal to an outline of an outer periphery of aflange 43 (see FIG. 2) in a container main body 40. The sealing member51 is heat-fused to the flange 43 of the container main body 40 using anadhesive. To be specific, the sealing member 51 is heat-fused to anelongated protrusion 45 of the flange 43. Differences of the sealingmember 51 from the sealing member 50 (see FIG. 4) according to the firstembodiment are an adhesive applied area 51 a and an adhesive non-appliedarea 51 b.

A thermoplastic adhesive (hot melt) is applied on the adhesive appliedarea 51 a. The area of the adhesive applied area Ma is smaller than thearea of the adhesive applied area 50 a (see FIG. 4) of the sealingmember 50 according to the first embodiment, but is larger than the areaof the flange 43 (see FIG. 2) of the container main body 40. Theadhesive applied area 51 a abuts on the elongated protrusion 45 providedon the flange 43 of the container main body 40. Following that, theabutting portion of the sealing member 51 and the elongated protrusion45 is warmed by a mold, so that an adhesive is melted, and the sealingmember 51 and the elongated protrusion 45 are heat-fused (glued).

Further, the adhesive is not applied on the adhesive non-applied area 51b. The adhesive non-applied area 51 b is set to an area facing an innersheet 60 (see FIG. 2).

A medical device package of the second embodiment having such aconfiguration can also exert an effect similar to the syringe package(medical device package) 80 of the first embodiment.

For example, the area of the adhesive applied area 51 a formed on thesealing member 51 is larger than the area of the flange 43 of thecontainer main body 40. Therefore, even if the sealing member 51 isshifted from the container main body 40 to some extent, the adhesiveapplied area 51 a of the sealing member 51 can abut on the elongatedprotrusion 45 on the flange 43 of the container main body 40, and theadhesive applied area 51 a and the elongated protrusion 45 can be glued.

Further, when sterilization processing is applied to the medical devicepackage of the second embodiment, the adhesive is not applied on an areaof the sealing member 51, the area being in contact with the inner sheet60, and thus the adhesive is not attached to the inner sheet 60. As aresult, the inner sheet 60 is not removed together with the sealingmember 51 at the time of opening the medical device package of thesecond embodiment, and a state in which a filling opening 15 side of aplurality of syringes 10 is covered with the inner sheet 60 can bemaintained.

3. Third Embodiment of Medical Device Package

[Configuration of Medical Device Package]

Next, a configuration of a medical device package according to a thirdembodiment will be described with reference to FIG. 7.

FIG. 7 is a perspective view of a sealing member in a medical devicepackage according to the third embodiment.

The medical device package according to the third embodiment has aconfiguration similar to the syringe package 80 (see FIG. 2) of thefirst embodiment. A difference of the medical device package of thethird embodiment from the syringe package 80 is only a sealing member.Therefore, here, a sealing member 52 in the medical device package ofthe third embodiment will be described.

[Sealing Member]

The sealing member 52 illustrated in FIG. 7 is formed into a squaresheet shape approximately equal to an outline of an outer periphery of aflange 43 (see FIG. 2) in a container main body 40. The sealing member52 is heat-fused to the flange 43 of the container main body 40 using anadhesive. To be specific, the sealing member 52 is heat-fused to anelongated protrusion 45 of the flange 43. Differences of the sealingmember 52 from the sealing member 50 (see FIG. 4) according to the firstembodiment are an adhesive applied area 52 a and an adhesive non-appliedarea 52 b.

A thermoplastic adhesive (hot melt) is applied on the adhesive appliedarea 52 a. The area of the adhesive applied area 52 a is smaller thanthe area of the adhesive applied area 50 a (see FIG. 4) of the sealingmember 50 according to the first embodiment, and is set to beapproximately equal to the area of the flange 43 (see FIG. 2) of thecontainer main body 40. The adhesive applied area 52 a abuts on theelongated protrusion 45 provided on the flange 43 of the container mainbody 40. Following that, the abutting portion of the sealing member 52and the elongated protrusion 45 is warmed by a mold, so that theadhesive is melted, and the sealing member 52 and the elongatedprotrusion 45 are heat-fused (glued).

The adhesive is not applied on the adhesive non-applied area 52 b. Theadhesive non-applied area 52 b is set to an area facing an opening 40 a(see FIG. 2).

Even the medical device package of the third embodiment having such aconfiguration can obtain an effect similar to the syringe package 80(medical device package) of the first embodiment.

For example, the area of the adhesive applied area 52 a formed on thesealing member 52 is set approximately equal to the area of the flange43 of the container main body 40. Therefore, even if the sealing member52 is shifted from the container main body 40 to some extent, theadhesive applied area 52 a of the sealing member 52 can abut on theelongated protrusion 45 on the flange 43 of the container main body 40,and the adhesive applied area 52 a and the elongated protrusion 45 canbe glued.

Further, when sterilization processing is applied to the medical devicepackage of the third embodiment, the adhesive is not applied on an areaof the sealing member 52, the area being in contact with an inner sheet60, and thus the adhesive is not attached to the inner sheet 60. As aresult, the inner sheet 60 is not removed together with the sealingmember 52 at the time of opening the medical device package of the thirdembodiment, and a state in which a filling opening 15 side of aplurality of syringes 10 is covered with the inner sheet 60 can bemaintained.

4. Fourth Embodiment of Medical Device Package

[Configuration of Medical Device Package]

Next, a configuration of a medical device package according to a fourthembodiment will be described with reference to FIGS. 8 and 9.

FIG. 8 is a longitudinal sectional view of a medical device packageaccording to the fourth embodiment of the present invention. FIG. 9 isan exploded view of the medical device package according to the fourthembodiment of the present invention.

As illustrated in FIGS. 8 and 9, a needle member package 180representing the medical device package according to the fourthembodiment is configured from a needle member storage container 100representing another specific example of the medical device storagecontainer, and a needle member 110 representing another specific exampleof the medical device stored in the needle member storage container 100.

The needle member storage container 100 is used when the needle member110 is conveyed/kept. The needle member storage container 100 includes acontainer main body 140 that holds and stores the needle member 110 anda sealing member 150.

[Container Main Body]

Next, the container main body 140 will be described.

As illustrated in FIG. 8, the container main body 140 includes aperipheral wall portion 142 including an upper end portion and a lowerend portion, a bottom 141 continuing to the lower end portion of theperipheral wall portion 142 and surrounded by the lower end portion, anopening 140 a surrounded by the upper end portion of the peripheral wallportion 142, and a flange 143 continuing to the upper end portion of theperipheral wall portion 142. An internal space of the container mainbody 140 surrounded by the peripheral wall portion 142, the bottom 141,and the opening 140 a is a storage space that stores the needle member110.

The bottom 141 is formed into an approximately circular plate shape, andconfigures a lower end of the container main body 140. The peripheralwall portion 142 is formed into an approximately cylindrical shape, andincludes a lower cylinder 146 continuing to the bottom 141, a taperedcylinder 147 continuing to the lower cylinder 146, and an upper cylinder148 continuing to the tapered cylinder 147. The diameter of the lowercylinder 146 is set smaller than that of the upper cylinder.

The tapered cylinder 147 is continuously increased in the diametertoward the upper cylinder 148 side. An inner surface of the taperedcylinder 147 is engaged with a cap member 120 described below attachedto the needle member 110. Further, a step portion 146 a is formed on aninner surface of the tapered cylinder 147 at the upper cylinder 148side. A connection portion 113 described below of the needle member 110abuts on the step portion 146 a, so that the needle member 110 is heldin the container main body 140. That is, the step portion 146 arepresents another specific example of the holding unit according to thepresent invention. Note that the step portion 146 a may be omitted. Inthis case, the cap member 120 is engaged with the inner surface of thetapered cylinder 147, so that the needle member 110 is held in thecontainer main body 140. That is, the inner surface of the taperedcylinder 147 represents another specific example of the holding unitaccording to the present invention.

The flange 143 is approximately perpendicular to an upper end of theperipheral wall portion 142, and is formed into an approximatelycircular frame shape. The flange 143 includes an upper surface 143 afacing an upper end and a lower surface 143 b facing a lower end. Theupper surface 143 a and the lower surface 143 b are formed into planes.

The container main body 140 is favorably not denatured by sterilizationprocessing using a high-temperature vapor or gas, such as high-pressurevapor sterilization (autoclave) or ethylene oxide gas (EOG)sterilization. Examples of a material for the container main body 140include resins having excellent durability, such as polypropylene,polystyrene, polyethylene, polycarbonate, an ABS resin, and PET.

[Sealing Member]

Next, the sealing member 150 will be described.

As illustrated in FIG. 9, the sealing member 150 is formed into a sheetshape, and includes a circular portion 150 a and a holding portion 150 bcontinuing to a part of the circular portion 150 a. An outer diameter ofthe circular portion 150 a is set to be slightly larger than an outlineof an outer periphery of the flange 143 of the container main body 140.The circular portion 150 a of the sealing member 150 is heat-fused tothe flange 143 of the container main body 140 using an adhesive. Theholding portion 150 b is formed into an approximately a triangle shapein which one side continues to the circular portion 150 a. The holdingportion 150 b is not glued to the container main body 140.

It is favorable that the sealing member 150 is permeable by a gas forsterilization and is not permeable by minute particles such as bacteriaor viruses. An example of a material for the sealing member 150 includesTyvek (registered trademark) that is a high-density polyethylenenonwoven fabric manufactured by Du Pont Kabushiki Kaisha. Note that thesealing member 150 formed of the high-density polyethylene nonwovenfabric is opaque.

An adhesive applied area 151 a and an adhesive non-applied area 151 bare formed on a surface of the sealing member 150, the surface facingthe container main body 140. A thermoplastic adhesive (hot melt) isapplied on the adhesive applied area 151 a. The adhesive applied area151 a abuts on the flange 143 of the container main body 140. Then, anabutting portion of the sealing member 150 and the flange 143 is warmedby a mold, so that the adhesive is melted, and the sealing member 150and the flange 143 are heat-fused (glued).

Further, the adhesive is not applied on the adhesive non-applied area151 b. The adhesive non-applied area 151 b is set to an area facing aconnection portion (one end surface) 113 described below of the needlemember 110 stored in the container main body 140.

[Needle Member]

Next, the needle member 110 will be described.

The needle member 110 illustrated in FIGS. 8 and 9 is attached to asyringe (a pen-type syringe, or the like), a tip portion of which issealed with a rubber plug. The needle member 110 includes a double endedneedle 111 including needles at both ends, a needle holding portion 112that holds a middle portion of the double ended needle 111, and theconnection portion 113 continuing to the needle holding portion 112.

As illustrated in FIG. 8, the needle holding portion 112 is formed intoan approximately columnar shape, and holds a middle portion of thedouble ended needle 111. The connection portion 113 is providedcontinuing to a one end portion of the needle holding portion 112 in anaxial direction, and is formed into an approximately cylindrical shapeincluding a cylinder hole 113 a. One end portion of the double endedneedle 111 is arranged in the connection portion 113.

In the present embodiment, an end surface of the connection portion 113at a side opposite to the needle holding portion 112 is one end surfaceof the needle member 110, and an end surface of the needle holdingportion 112 at a side opposite to the connection portion 113 is theother end surface of the needle member 110. The one end surface of theneedle member 110 faces the sealing member 150. Further, an end surfaceof the connection portion 113 at a side of the needle holding portion112 abuts on the step portion 146 a of the container main body 140.

A female screw portion 113 b is formed on an inner peripheral surface ofthe connection portion 113. A tip portion of a syringe, a tip of whichis sealed with a rubber plug, is screwed with the connection portion113. That is, a male screw portion to be screwed with the female screwportion 113 b of the needle member 110 is provided at the tip portion ofthe syringe. When the tip portion of the syringe is connected to theconnection portion 113 of the needle member 110, a needle tip formed onthe one end portion of the double ended needle 111 punctures the rubberplug that seals the tip portion of the syringe. As a result, the doubleended needle 111 and the internal space of the syringe communicate witheach other.

The cap member 120 is attached to the needle holding portion 112. Thecap member 120 is formed into an approximately cylindrical shape, andone end in the axial direction is opened and the other end in the axialdirection is closed. The cap member 120 covers the other end portion ofthe double ended needle 111 protruding from the needle holding portion112. Further, a protrusion 121 engaged with the inner surface of thetapered cylinder 147 in the container main body 140 is provided on anouter peripheral surface of the cap member 120.

The needle member package 180 having such a configuration can obtain aneffect similar to the syringe packages of the first to thirdembodiments. That is, when sterilization processing is applied to theneedle member package 180, the sealing member 150 is pressed to bedented toward an inner side of the container main body 140 by thehigh-temperature vapor or gas. Therefore, a surface of the sealingmember 150, the surface facing the container main body 140, abuts on anend surface of the connection portion 113 in the needle member 110.

As described above, an area facing the connection portion 113 side, onthe surface of the sealing member 150, the surface facing the containermain body 140, is the adhesive non-applied area 151 b where the adhesiveis not applied. Therefore, if the surface of the sealing member 150, thesurface facing the container main body 140, abuts on the end surface ofthe connection portion 113 in the needle member 110, the adhesive is notattached to the connection portion 113.

5. Modification

Embodiments of medical device packages have been described including itseffect. However, the medical device packages of the present inventionare not limited to the embodiments described above and illustrated inthe drawings, and various modifications can be made without departingfrom the gist of the invention described in the claims.

For example, the medical device packages of the first to thirdembodiments have configurations that store the syringe 10 as a specificexample of the medical device. Further, the medical device package ofthe fourth embodiment has a configuration that stores the needle member110 as another specific example of the medical device. However, as themedical device according to the present invention, a connector thatconnects tubes, a syringe and a tube, or an agent container and a tubemay be applied.

Further, in the first to fourth embodiment, the sealing members aremanufactured such that the adhesive is applied on the portion serving asthe adhesive applied area of a nonwoven fabric. However, a sealingmember according to the present invention may be manufactured such thata nonwoven fabric formed into a size of the adhesive non-applied area isbonded to a nonwoven fabric, the entire of which is applied theadhesive.

Further, to maintain a state in which a filling opening 15 side of aplurality of syringes 10 is covered with an inner sheet 60, two sheetsor more inner sheets 60 may be layered and placed on flange portions 16of the syringes 10.

In this case, even if the adhesive is applied to the entire surface ofthe sealing member, the surface facing a container main body 40, a topinner sheet 60 or a several number of the inner sheets 60 from the topinner sheet 60 is glued to the sealing member. Then, the filling opening15 side of the plurality of syringes 10 can be covered with a bottominner sheet 60 or a several number of the inner sheets 60 from thebottom inner sheet 60.

Further, the first to third embodiments have configurations in which themedical device package includes the inner sheet 60. However, the medicaldevice package of the present invention may have a configuration withoutincluding an inner sheet 60. For example, when a syringe package isopened in an environment without bacteria and dust and a drug solutionis filled in the syringe, the bacteria and dust do not enter thesyringes even if a filling opening side of the syringes is exposed. Inthis case, the inner sheet 60 can be omitted.

Further, in the first embodiment, the adhesive non-applied area 50 b ofthe sealing member 50 is an area facing the plurality of syringes 10. Inthe second embodiment, the adhesive non-applied area 51 b of the sealingmember 51 is an area facing the inner sheet 60. In the third embodiment,the adhesive non-applied area 52 b of the sealing member 52 is an areafacing the opening 40 a. However, the adhesive non-applied areaaccording to the present invention is not limited to these embodiments,and may be an area including an area facing at least a plurality ofsyringes 10 and not to hinder gluing of the sealing member and thecontainer main body.

As the adhesive non-applied area according to the present invention, anarea facing a portion at an inner side of the outline of the innerperiphery of the elongated protrusion 45 provided on the flange 43 ofthe container main body 40 may be set to the adhesive non-applied area.That is, the adhesive applied area may be set to an area facing theelongated protrusion 45. In this case, the amount of the adhesive to beused can be decreased, and thus cost required for manufacturing themedical device package can be decreased. Note that, in this case, it isnecessary to highly accurately position the sealing member and thecontainer main body to avoid gluing failure.

Further, the first to third embodiments have the configurations in whichthe elongated protrusion 45 that serves as the glued portion with thesealing member is provided on the flange 43 of the container main body40. However, as the container main body according to the presentinvention, a container main body in which an elongated protrusion 45 isnot formed on a flange 43 may be employed. In this case, the sealingmember is heat-fused (is glued) to an upper surface 43 a of the flange43.

When such a container main body is used, a sealing member 50 includingan adhesive applied area 50 a having a larger area than the flange 43 ora sealing member 51 including an adhesive applied area 51 a having alarger area than the flange 43 may be favorably employed. Accordingly,even if the sealing member 50 or 51 is shifted from the container mainbody to some extent, the adhesive applied area 50 a or 51 a abuts on theflange 43 of the container main body, and the adhesive applied area 50 aor 52 a and the flange 43 can be glued.

Further, in the first to third embodiments, the mounting shelf 44 isformed such that the longitudinal sectional view of the peripheral wallportion 42 is formed into a crank shape. However, as the mounting shelfaccording to the present invention, a protrusion portion continuing toan inner surface of a peripheral wall portion and protrudingapproximately parallel to a bottom 41 may be employed.

Further, the mounting shelf according to the present invention is notnecessarily continuing along an inner wall surface of the peripheralwall portion in a peripheral direction, and may be provideddiscontinuing along the inner wall surface of the peripheral wallportion as long as the mounting shelf can support the syringe holdingmember. In this case, the mounting shelf may be formed of a plurality ofribs continuing to the inner surface of the peripheral wall portion andthe bottom 41, and protruding approximately parallel to the bottom 41.

Further, in the first to third embodiments, the container main body 40is formed into a box shape with an upper portion open. However, thecontainer main body according to the present invention may be formedinto a cylindrical shape with a bottom.

Further, in the first to third embodiments, description has been madetaking the syringe storage container 1 and the syringe package 80 thatstore the syringe 10 with a needle, as examples. However, the medicaldevice package of the present invention may store a syringe to which noneedle is attached.

Further, the syringe holding member 30 of the first to third embodimentholds the syringe 10 such that the filling opening 15 faces upward(faces an upper end). However, as the method of filling a drug solution(agent) to a syringe, there is a method of filling a drug solution(agent) from a discharge portion of the syringe using a filling nozzle.When the drug solution (agent) is filled to the syringe using such amethod, the syringe is held by the syringe holding member such that thedischarge portion faces upward (faces an upper end). In this case, thedischarge portion of the syringe also serves as a filling opening forfilling the drug solution, and the discharge portion side of the syringeis the one end surface of the medical device according to the presentinvention.

Further, in the first to third embodiments, the sealing members formedinto a square shape approximately equal to the outline of the outerperiphery of the flange 43 are used. However, as the sealing memberaccording to the present invention, a sealing member formed into a longbelt shape, and wound and kept in a roll manner may be used.

A method of assembling a syringe package (medical device package) inthis case is as follows. A large number of container main bodies 40 inwhich the syringe holding member 30 that holds the syringes 10 ismounted are arranged. Next, the sealing member enough to cover the largenumber of arranged container main bodies 40 is pulled out from the roll,and is placed on the elongated protrusions 45 of the large number ofcontainer main bodies 40. Following that, the sealing member is heatedand pressurized by a metal mold corresponding to the size of the pulledsealing member, and the elongated protrusions 45 and the sealing memberare heat-fused using an adhesive. Following that, the sealing member iscut along the outline of the outer periphery of the flange 43 in eachcontainer main bodies 40, whereby the syringe package 80 can beassembled.

Embodiments of the present invention can be used for a medical devicecontainer that stores medical devices.

What is claimed is:
 1. A drug solution container package comprising: aplurality of drug solution containers, each including: a first endportion, a second end portion opposite to the first end portion and, amain body portion that is disposed between the first end portion andsecond end portion, wherein the first end portion includes a fillingopening and a first end surface that surrounds the filling opening, andwherein the main body portion has a chamber therein configured to befilled with a drug solution via the filling opening; and a storagecontainer storing the plurality of drug solution containers, the storagecontainer comprising: a container main body including: a peripheral wallportion having an upper end portion and a lower end portion, a bottomthat is continuous with the lower end portion and surrounded by thelower end portion, an opening surrounded by the upper end portion, aflange portion that is continuous with the upper end portion andsurrounds the upper end portion, and a storage space formed inside theperipheral wall portion and the bottom, a holding portion located in thestorage space, the holding portion holding the plurality of drugsolution containers such that each of the first end surfaces of theplurality of drug solution containers faces upward a sealing membercomprising a nonwoven fabric sheet that is permeable to gas and/or vaporbut impermeable to minute particles, the nonwoven fabric sheet having alower surface that faces the bottom of the container main body and anupper surface that is exposed outside of the container main body, and aheat-melted adhesive disposed on the lower surface of the nonwovenfabric sheet, the sealing member being adhered to the flange portion ofthe container main body via the adhesive to seal the opening of thecontainer main body, wherein the lower surface of the nonwoven fabricsheet includes an adhesive applied area on which the adhesive is appliedand an adhesive non-applied area on which the adhesive is not applied,wherein the adhesive non-applied area faces each of the first endsurfaces of the plurality of drug solution containers and the adhesiveapplied area faces the flange portion of the container main body,wherein a boundary between the adhesive applied area and the adhesivenon-applied area is located on an outward side of the first end surfacesof outermost ones of the plurality of drug solution containers.
 2. Thedrug solution container package according to claim 1, wherein theboundary between the adhesive applied area and the adhesive non-appliedarea is located on an inward side of the flange portion of the containermain body.
 3. The drug solution container package according to claim 1,further comprising: an inner sheet configured to cover each of the firstend surfaces of the plurality of drug solution containers held by theholding portion, wherein the adhesive non-applied area of the nonwovenfabric sheet faces the first end surfaces of the drug solutioncontainers via the inner sheet.
 4. The drug solution container packageaccording to claim 3, wherein the adhesive non-applied area includes atleast an area facing the inner sheet.
 5. The drug solution containerpackage according to claim 1, wherein the adhesive non-applied areaincludes at least an area facing the opening.
 6. The drug solutioncontainer package according to claim 1, the boundary between theadhesive applied area and the adhesive non-applied area extends alongthe flange portion of the container main body.
 7. The drug solutioncontainer package according to claim 1, wherein: the sealing member ispermeable by high-pressure vapor, and the plurality of drug solutioncontainers stored in the container main body are sterilizable viahigh-pressure vapor that permeates the sealing member.
 8. The drugsolution container package according to claim 1, wherein the boundarybetween the adhesive applied area and the adhesive non-applied area islocated at an inward side of the flange portion of the container mainbody and extends along the flange portion of the container main body. 9.The drug solution container package according to claim 1, wherein acentral portion of the sealing member is located lower than a portion ofthe sealing member adjacent to the flange portion of the container mainbody.
 10. A method of manufacturing a drug solution container package,the method comprising: providing a plurality of drug solutioncontainers, each including: a first end portion, a second end portionopposite to the first end portion, and a main body portion that isdisposed between the first end portion and second end portion, whereinthe first end portion includes a filling opening and a first end surfacethat surrounds the filling opening, and wherein the main body portionhas a chamber therein configured to be filled with a drug solution viathe filling opening; and providing a storage container comprising: acontainer main body including: a peripheral wall portion having an upperend portion and a lower end portion, a bottom that is continuous withthe lower end portion and surrounded by the lower end portion, anopening surrounded by the upper end portion, a flange portion that iscontinuous with the upper end portion and surrounds the upper endportion, and a storage space formed inside the peripheral wall portionand the bottom; a holding portion located in the storage space; and asealing member comprising a nonwoven fabric sheet that is permeable togas and/or vapor but impermeable to minute particles, the nonwovenfabric sheet having a lower surface that faces the bottom of thecontainer main body the bottom of the container main body and an uppersurface that is exposed outside of the container main body, wherein thelower surface of the nonwoven fabric sheet includes an adhesive appliedarea on which a heat-meltable adhesive is applied and an adhesivenon-applied area on which the adhesive is not applied; placing theplurality of drug solution containers in the holding portion of thestorage container such that each of the first end surfaces of theplurality of drug solution containers faces upward; adhering the sealingmember is to the container main body by melting the adhesive to seal theopening of the container main body, such that the adhesive non-appliedarea faces each of the first end surfaces of the plurality of drugsolution containers and the adhesive applied area faces the flangeportion of the container main body, and such that a boundary between theadhesive applied area and the adhesive non-applied area is located on anoutward side of the first end surfaces of outermost ones of theplurality of drug solution containers.
 11. The method according to claim10, wherein the method further comprises deforming the sealing membersuch that a central portion of the sealing member protrudes toward thebottom of the container main body and such that the central portion islocated lower than a portion of the sealing member adjacent to theflange portion of the container main body but does not contact anyportion of the bottom of the container main body.
 12. The methodaccording to claim 10, wherein the deforming of the sealing member isperformed while using a high-temperature vapor or gas to sterilize thepackage assembly.